Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
A panel of monoclonal antibodies for the type I insulin-like growth factor receptor
Its mechanisms of action have been primarily explored in non-clinical studies involving animal models, cell cultures, and limited human cohorts
Phase 2 - Staying the Course (month 3 and beyond) Dose: 0.5 to 1.5 mg weekly
The without-DAC form (Mod GRF 1-29) lacks this linker and is a chemically distinct 29-amino-acid molecule with an extrapolated half-life closer to 30 minutes
-Glutamylcysteine Synthetase and -glutamyl Transferase as Differential Enzymatic Sources of -glutamylpeptides in Mice
US$ 25.52
US$ 26.43
US$ 22.59
